{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:31:46Z","timestamp":1750307506360,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":30,"publisher":"ACM","license":[{"start":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T00:00:00Z","timestamp":1247011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,7,8]]},"DOI":"10.1145\/1570256.1570382","type":"proceedings-article","created":{"date-parts":[[2009,7,21]],"date-time":"2009-07-21T13:32:17Z","timestamp":1248183137000},"page":"2679-2684","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["A PSO\/ACO approach to knowledge discovery in a pharmacovigilance context"],"prefix":"10.1145","author":[{"given":"Margarita","family":"Sordo","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}]},{"given":"Gabriela","family":"Ochoa","sequence":"additional","affiliation":[{"name":"School of Computer Science, University of Nottingham, Nottingham, United Kingdom"}]},{"given":"Shawn N.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}]}],"member":"320","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"doi-asserted-by":"crossref","unstructured":"Beddhu S. Allen-Brady K. Cheung A.K. Horne B.D. Bair T. Muhlestein J.B. and Anderson J.L. Impact of renal failure on the risk of myocardial infarction and death. Kidney International (2002) 62 1776--1783.  Beddhu S. Allen-Brady K. Cheung A.K. Horne B.D. Bair T. Muhlestein J.B. and Anderson J.L. Impact of renal failure on the risk of myocardial infarction and death. Kidney International (2002) 62 1776--1783.","key":"e_1_3_2_1_1_1","DOI":"10.1046\/j.1523-1755.2002.00629.x"},{"doi-asserted-by":"crossref","unstructured":"Booth G.L. Kapral M.K. Fung K.T. Jack V. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. The Lancet 2006; 368(9529):29--36.  Booth G.L. Kapral M.K. Fung K.T. Jack V. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. The Lancet 2006; 368(9529):29--36.","key":"e_1_3_2_1_2_1","DOI":"10.1016\/S0140-6736(06)68967-8"},{"doi-asserted-by":"crossref","unstructured":"Brownstein J.S. Sordo M. Kohane I.S. Mandl K.D. The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction. PLoS ONE 2007;2(9):e840.  Brownstein J.S. Sordo M. Kohane I.S. Mandl K.D. The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction. PLoS ONE 2007;2(9):e840.","key":"e_1_3_2_1_4_1","DOI":"10.1371\/journal.pone.0000840"},{"doi-asserted-by":"publisher","key":"e_1_3_2_1_5_1","DOI":"10.1177\/014107680609900315"},{"key":"e_1_3_2_1_6_1","volume-title":"Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000;283(24): 3223--9","author":"Canto J.G.","year":"2000","unstructured":"Canto J.G. , Shlipak M.G. , Rogers W.J. , Malmgren J.A. , Frederick P.D. , Lambrew C.T. , Ornato J.P. , Barron H.V. , Kiefe C.I. ( 2000 ). Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000;283(24): 3223--9 . Canto J.G., Shlipak M.G., Rogers W.J., Malmgren J.A., Frederick P.D., Lambrew C.T., Ornato J.P., Barron H.V., Kiefe C.I. (2000). Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000;283(24): 3223--9."},{"doi-asserted-by":"publisher","key":"e_1_3_2_1_7_1","DOI":"10.1007\/11564126_45"},{"doi-asserted-by":"crossref","unstructured":"Dormandy J.A. Charbonnel B. Eckland D.J. etal Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 2005;366(9493):1279--89.  Dormandy J.A. Charbonnel B. Eckland D.J. et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 2005;366(9493):1279--89.","key":"e_1_3_2_1_8_1","DOI":"10.1016\/S0140-6736(05)67528-9"},{"unstructured":"FDA issues public health advisory on Vioxx as its manufacturer voluntarily withdraws the product. FDA News. 2004 Sep 30. http:\/\/www.fda.gov\/bbs\/topics\/news\/2004\/new01122.html  FDA issues public health advisory on Vioxx as its manufacturer voluntarily withdraws the product. FDA News. 2004 Sep 30. http:\/\/www.fda.gov\/bbs\/topics\/news\/2004\/new01122.html","key":"e_1_3_2_1_9_1"},{"doi-asserted-by":"crossref","unstructured":"Gerrits C.M. Bhattacharya M. Manthena S. Baran R. Perez A. Kupfer S. A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes. Pharmacoepidemiol Drug Saf 2007;16(10):1065--71.  Gerrits C.M. Bhattacharya M. Manthena S. Baran R. Perez A. Kupfer S. A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes. Pharmacoepidemiol Drug Saf 2007;16(10):1065--71.","key":"e_1_3_2_1_10_1","DOI":"10.1002\/pds.1470"},{"doi-asserted-by":"publisher","key":"e_1_3_2_1_11_1","DOI":"10.1016\/S0140-6736(05)17864-7"},{"key":"e_1_3_2_1_12_1","volume-title":"Proceedings of Medical Informatics Association (MedInfo)","author":"Greenes R.A.","year":"2004","unstructured":"Greenes R.A. , Sordo M. , Zaccagnini D. , Meyer M. , Kuperman G.J. Design of a Standards-Based External Rules Engine for Decision Support in a Variety of Application Contexts: Report of a Feasibility Study at Partners HealthCare System . Proceedings of Medical Informatics Association (MedInfo) , September , 2004 . Greenes R.A., Sordo M., Zaccagnini D., Meyer M., Kuperman G.J. Design of a Standards-Based External Rules Engine for Decision Support in a Variety of Application Contexts: Report of a Feasibility Study at Partners HealthCare System. Proceedings of Medical Informatics Association (MedInfo), September, 2004."},{"doi-asserted-by":"crossref","unstructured":"Haffner S.M. Lehto S. Ronnemaa T. Pyorala K. Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339(4):229--34.  Haffner S.M. Lehto S. Ronnemaa T. Pyorala K. Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339(4):229--34.","key":"e_1_3_2_1_13_1","DOI":"10.1056\/NEJM199807233390404"},{"doi-asserted-by":"crossref","unstructured":"He J. Ogden L.G. Bazzano L.A. etal Risk factors for congestive heart failure in U.S. men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001; 161: 996--1002.  He J. Ogden L.G. Bazzano L.A. et al. Risk factors for congestive heart failure in U.S. men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001; 161: 996--1002.","key":"e_1_3_2_1_14_1","DOI":"10.1001\/archinte.161.7.996"},{"key":"e_1_3_2_1_15_1","volume-title":"Epidemiology in Medicine","author":"Hennekens C.H.","year":"1987","unstructured":"Hennekens C.H. , Buring J. Epidemiology in Medicine . Little Brown and Co. 1987 . Hennekens C.H., Buring J. Epidemiology in Medicine. Little Brown and Co. 1987."},{"doi-asserted-by":"publisher","key":"e_1_3_2_1_16_1","DOI":"10.1136\/bmj.330.7504.1366"},{"doi-asserted-by":"publisher","key":"e_1_3_2_1_17_1","DOI":"10.1145\/1274000.1274080"},{"doi-asserted-by":"publisher","key":"e_1_3_2_1_18_1","DOI":"10.1155\/2008\/316145"},{"unstructured":"Holden N. Freitas A.A. PSO\/ACO2 Java application. Downloads at http:\/\/sourceforge.net\/projects\/psoaco2\/  Holden N. Freitas A.A. PSO\/ACO2 Java application. Downloads at http:\/\/sourceforge.net\/projects\/psoaco2\/","key":"e_1_3_2_1_19_1"},{"key":"e_1_3_2_1_20_1","volume-title":"September 22","author":"Institute of Medicine","year":"2006","unstructured":"Institute of Medicine , The Future of Drug Safety- Promoting and Protecting the Health of the Public , September 22 , 2006 , http:\/\/www.iom.edu\/. Institute of Medicine, The Future of Drug Safety- Promoting and Protecting the Health of the Public, September 22, 2006, http:\/\/www.iom.edu\/."},{"key":"e_1_3_2_1_21_1","volume-title":"May 1","author":"King III","year":"2000","unstructured":"S.B. King III . Acute myocardial infarction: are diabetics different? J. Am. Coll. Cardiol ., May 1 , 2000 ; 35(6): 1513--1515. S.B. King III. Acute myocardial infarction: are diabetics different? J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1513--1515."},{"key":"e_1_3_2_1_22_1","volume-title":"Heart Disease: A Textbook of Cardiovascular Medicine","author":"Nesto R.","year":"2001","unstructured":"Nesto R. , Libby P. Diabetes mellitus and the cardiovascular system . In: Braunwald E., Zipes D.P., Libby P., eds. Heart Disease: A Textbook of Cardiovascular Medicine . 6 th ed. Philadelphia, Pa : W.B. Saunders Co ; 2001 : 2133--2150. Nesto R., Libby P. Diabetes mellitus and the cardiovascular system. In: Braunwald E., Zipes D.P., Libby P., eds. Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia, Pa: W.B. Saunders Co; 2001: 2133--2150.","edition":"6"},{"doi-asserted-by":"crossref","unstructured":"Nichols G.A. Hillier T.A. Erbey J.R. etal Congestive heart failure in type 2 diabetes: prevalence incidence and risk factors. Diabetes Care. 2001; 24: 1614--1619.  Nichols G.A. Hillier T.A. Erbey J.R. et al. Congestive heart failure in type 2 diabetes: prevalence incidence and risk factors. Diabetes Care. 2001; 24: 1614--1619.","key":"e_1_3_2_1_23_1","DOI":"10.2337\/diacare.24.9.1614"},{"doi-asserted-by":"crossref","unstructured":"Nissen S.E. Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes {published correction appears N Engl J Med. 2007;357(1): 100}. N Engl J Med 2007;356(24):2457--2471.  Nissen S.E. Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes {published correction appears N Engl J Med. 2007;357(1): 100}. N Engl J Med 2007;356(24):2457--2471.","key":"e_1_3_2_1_24_1","DOI":"10.1056\/NEJMoa072761"},{"doi-asserted-by":"crossref","unstructured":"Qaseem A. Vijan S. Snow V. Cross T. Weiss K.B. Owens D.K. Glycemic Control and Type 2 Diabetes Mellitus: The Optimal Hemoglobin A1C Targets. A Guidance Statement from the American College of Physicians. Ann Inter Med 2007; 147: 417--422.  Qaseem A. Vijan S. Snow V. Cross T. Weiss K.B. Owens D.K. Glycemic Control and Type 2 Diabetes Mellitus: The Optimal Hemoglobin A1C Targets. A Guidance Statement from the American College of Physicians. Ann Inter Med 2007; 147: 417--422.","key":"e_1_3_2_1_25_1","DOI":"10.7326\/0003-4819-147-6-200709180-00012"},{"doi-asserted-by":"crossref","unstructured":"Singer D.E. Nathan D.M. Anderson K.M. Wilson P.W. Evans J.C. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes Vol 41 Issue 2 202--208.  Singer D.E. Nathan D.M. Anderson K.M. Wilson P.W. Evans J.C. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes Vol 41 Issue 2 202--208.","key":"e_1_3_2_1_26_1","DOI":"10.2337\/diabetes.41.2.202"},{"doi-asserted-by":"crossref","unstructured":"Singh S. Loke Y.K. Furberg CD. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA. 2007;298(10):1189--1195.  Singh S. Loke Y.K. Furberg CD. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA. 2007;298(10):1189--1195.","key":"e_1_3_2_1_27_1","DOI":"10.1001\/jama.298.10.1189"},{"doi-asserted-by":"publisher","key":"e_1_3_2_1_28_1","DOI":"10.1161\/01.CIR.0000127578.21885.3E"},{"doi-asserted-by":"publisher","key":"e_1_3_2_1_29_1","DOI":"10.1056\/NEJMoa050405"},{"doi-asserted-by":"crossref","unstructured":"Yki-Jarvinen H. Thiazolidinediones. N Engl J Med. 2004; 351(11):1106--1118.  Yki-Jarvinen H. Thiazolidinediones. N Engl J Med. 2004; 351(11):1106--1118.","key":"e_1_3_2_1_30_1","DOI":"10.1056\/NEJMra041001"},{"doi-asserted-by":"crossref","unstructured":"Winkelmayer W.C. Setoguchi S. Levin R. Solomon D.H. Comparison of Cardiovascular Outcomes in Elderly Patients With Diabetes Who Initiated Rosiglitazone vs Pioglitazone Therapy. Arch Intern Med 2008;168(21):2368--75.  Winkelmayer W.C. Setoguchi S. Levin R. Solomon D.H. Comparison of Cardiovascular Outcomes in Elderly Patients With Diabetes Who Initiated Rosiglitazone vs Pioglitazone Therapy. Arch Intern Med 2008;168(21):2368--75.","key":"e_1_3_2_1_31_1","DOI":"10.1001\/archinte.168.21.2368"}],"event":{"sponsor":["SIGEVO ACM Special Interest Group on Genetic and Evolutionary Computation","ACM Association for Computing Machinery"],"acronym":"GECCO09","name":"GECCO09: Genetic and Evolutionary Computation Conference","location":"Montreal Qu\u00e9bec Canada"},"container-title":["Proceedings of the 11th Annual Conference Companion on Genetic and Evolutionary Computation Conference: Late Breaking Papers"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/1570256.1570382","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/1570256.1570382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T12:17:54Z","timestamp":1750249074000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/1570256.1570382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,8]]},"references-count":30,"alternative-id":["10.1145\/1570256.1570382","10.1145\/1570256"],"URL":"https:\/\/doi.org\/10.1145\/1570256.1570382","relation":{},"subject":[],"published":{"date-parts":[[2009,7,8]]},"assertion":[{"value":"2009-07-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}